New strategic partnership to develop next-generation T cell detection reagents

Polaris Biology and Tetramer Shop combine forces to accelerate state-of-the-art single-cell analysis capacity

07-Jul-2020 - Denmark

Two MedTech companies, Polaris Biology of China and Tetramer Shop of Denmark, announce a strategic partnership to co-develop and distribute technologies that accelerate T cell science. First on the agenda is to commercialize metal-labelled MHC tetramers for distribution in China.

Conventional fluorophore labelled tetramers are restricted by spectral overlap and compensation issues. With quick, easy access to metal-labelled tetramers, researchers will be able to detect hundreds of T cell specificities in a single sample, accelerating therapeutic development.

"Our partnership with Tetramer Shop will allow us to extend our immunophenotyping capability to antigen specificity analysis," says Shuangwu Sun, partner of Polaris Biology. "And our co-development of metal-labelled tetramers will enable us to accelerate our high-throughput single-cell analysis capacity. This has positive implications for the development of personalized therapeutic modalities here in China."

Founder and CEO of Tetramer Shop, Søren N. Jakobsen, says, "Since our first contact, we have been impressed by the expertise and diligence of the Polaris team, Dr. Shuangwu Sun and colleagues, within state-of-the-art single-cell analysis technologies. We could not have found a better partner and we are looking forward to a fruitful endeavour."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances